David S. Ettinger
Impact in
- Oncology top 0.2%
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
- Cancer Immunotherapy and Biomarkers
- Pulmonary and Respiratory Medicine top 0.2%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 174
- Lung Cancer Research Studies 92
- Cancer Treatment and Pharmacology 35
- Colorectal Cancer Treatments and Studies 19
- Peptidase Inhibition and Analysis 16
-
- Lung Cancer Treatments and Mutations 97
- Lung Cancer Diagnosis and Treatment 48
- Co-authors
- Eric K. RowinskyJohn C. RuckdeschelDianne M. FinkelsteinMartin D. AbeloffL B GrochowRoss C. DonehowerS E SartoriusArlene A. Forastiere
- Journals
- Journal of Clinical Oncology (41 papers)Cancer (20 papers)International Journal of Radiation Oncology*Biology*Physics (19 papers)Journal of the National Comprehensive Cancer Network (13 papers)Lung Cancer (13 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
David S. Ettinger
274 papers receiving 10.4k citations
Hit Papers
Peers
Comparison fields: 5 of 161
- Oncology 6.2k
- Pulmonary and Respiratory Medicine 4.4k
- Epidemiology 1.8k
- Otorhinolaryngology 219
- Cancer Research 683
Countries citing papers authored by David S. Ettinger
This map shows the geographic impact of David S. Ettinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S. Ettinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S. Ettinger more than expected).
Fields of papers citing papers by David S. Ettinger
This network shows the impact of papers produced by David S. Ettinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S. Ettinger. The network helps show where David S. Ettinger may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David S. Ettinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2020 | 7 | |
| 3 | 2018 | 14 | |
| 4 | 2015 | 5 | |
| 5 | 2014 | 28 | |
| 6 | 2013 | 117 | |
| 7 | 2011 | 35 | |
| 8 | 2011 | 18 | |
| 9 | 2010 | 20 | |
| 10 | International Consensus Panel Recommendations for the diagnosis of bone metastases (METS) from lung cancer (LC) | 2008 | 4 |
| 11 | Dual inhibition of the epidermal growth factor receptor (EGFR) pathway with the combination of cetuximab and erlotinib: A phase I study in patients with advanced solid malignancies | 2007 | 2 |
| 12 | 2007 | 19 | |
| 13 | Update: NCCN small cell and non-small cell lung cancer Clinical Practice Guidelines. | 2005 | 32 |
| 14 | 2002 | 4 | |
| 15 | 1997 | 74 | |
| 16 | 1996 | 21 | |
| 17 | 1994 | 6 | |
| 18 | 1992 | 302 | |
| 19 | 1990 | 4 | |
| 20 | 1985 | 3 |
About David S. Ettinger
David S. Ettinger is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Hepatology, Epidemiology and Otorhinolaryngology, having authored 280 papers that have together received 10.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (97 papers), Lung Cancer Research Studies (92 papers), Lung Cancer Diagnosis and Treatment (48 papers), Neuroendocrine Tumor Research Advances (44 papers), Cancer therapeutics and mechanisms (39 papers), Cancer Treatment and Pharmacology (35 papers), Colorectal Cancer Treatments and Studies (19 papers) and Peptidase Inhibition and Analysis (16 papers). The work is most often cited by research in Oncology (6.2k citations), Pulmonary and Respiratory Medicine (4.4k citations), Epidemiology (1.8k citations), Otorhinolaryngology (219 citations) and Cancer Research (683 citations). David S. Ettinger has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Eric K. Rowinsky, John C. Ruckdeschel, Dianne M. Finkelstein, Martin D. Abeloff, L B Grochow, Ross C. Donehower, S E Sartorius, Arlene A. Forastiere, R E Gregory and Julie R. Brahmer. Their work appears in journals such as Journal of Clinical Oncology, Cancer, International Journal of Radiation Oncology*Biology*Physics, Journal of the National Comprehensive Cancer Network and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.